Upadacitinib-impurities | Pharmaffiliates

Upadacitinib

Upadacitinib, sold under the brand name Rinvoq, is a Janus kinase (JAK) inhibitor medication for the treatment of moderately to severely active rheumatoid arthritis in adults. where, its methotrexate a drug used to treat active arthritis. Reference standards of Upadacitinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

PA 21 0180000

Upadacitinib - API


  • Catalogue No.:PA 21 0180000

  • CAS :

    1310726-60-3

  • Molecular Formula : C17H19F3N6O

  • Molecular Weight : 380.38

PA 21 0181000

(3S,4S)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide


  • Catalogue No.:PA 21 0181000

  • CAS :

    NA

  • Molecular Formula : C17H19F3N6O

  • Molecular Weight : 380.38

PA 21 0181002

(3R,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide


  • Catalogue No.:PA 21 0181002

  • CAS :

    NA

  • Molecular Formula : C17H19F3N6O

  • Molecular Weight : 380.38

PA 21 0181003

(3S,4R)-3-Ethyl-4-(3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide


  • Catalogue No.:PA 21 0181003

  • CAS :

    2411540-30-0

  • Molecular Formula : C24H25F3N6O3S

  • Molecular Weight : 534.56